NANOVIRICIDES, INC. Stock Issued During Period, Value, Employee Benefit Plan
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- NANOVIRICIDES, INC. stock issued during period, value, employee benefit plan for the quarter ending 2026-03-31 was $1.73K, a 18.54% decline year-over-year.
- NANOVIRICIDES, INC. stock issued during period, value, employee benefit plan for the quarter ending 2025-03-31 was $2.13K, a 9.19% decline year-over-year.
- NANOVIRICIDES, INC. stock issued during period, value, employee benefit plan for the quarter ending 2024-03-31 was $2.34K, a 51.47% decline year-over-year.
- NANOVIRICIDES, INC. stock issued during period, value, employee benefit plan for the quarter ending 2023-03-31 was $4.82K, a 28.75% decline year-over-year.
- NANOVIRICIDES, INC. stock issued during period, value, employee benefit plan for fiscal 2025 was $2.13K, a 9.19% decline from fiscal 2024.
- NANOVIRICIDES, INC. stock issued during period, value, employee benefit plan for fiscal 2024 was $2.34K, a 51.47% decline from fiscal 2023.
- NANOVIRICIDES, INC. stock issued during period, value, employee benefit plan for fiscal 2023 was $4.82K, a 28.75% decline from fiscal 2022.
- NANOVIRICIDES, INC. stock issued during period, value, employee benefit plan for fiscal 2022 was $6.77K, a 54.99% decline from fiscal 2021.
| Period end | Stock Issued During Period, Value, Employee Benefit Plan 3 month | Stock Issued During Period, Value, Employee Benefit Plan 12 month |
|---|---|---|
| 2026-03-31 | $1.73K 10-Q · filed 2026-05-15 | |
| 2025-06-30 | $2.13K 10-K · filed 2025-09-29 | |
| 2025-03-31 | $2.13K 10-Q · filed 2026-05-15 | |
| 2024-06-30 | $2.34K 10-K · filed 2025-09-29 | |
| 2024-03-31 | $2.34K 10-Q · filed 2025-05-15 | |
| 2023-06-30 | $4.82K 10-K · filed 2024-09-27 | |
| 2023-03-31 | $4.82K 10-Q · filed 2024-05-15 | |
| 2022-06-30 | $6.77K 10-K · filed 2023-10-13 | |
| 2022-03-31 | $6.77K 10-Q · filed 2023-05-15 | |
| 2021-06-30 | $15.04K 10-K · filed 2022-10-13 | |
| 2021-03-31 | $15.04K 10-Q · filed 2022-05-16 | |
| 2020-06-30 | $29.25K 10-K · filed 2021-10-12 | |
| 2020-03-31 | $29.25K 10-Q · filed 2021-05-14 | |
| 2019-06-30 | $28.57K 10-K · filed 2021-10-12 | |
| 2019-03-31 | $28.57K 10-Q · filed 2020-06-22 | |
| 2018-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-10-13 | $65.72K 10-K · filed 2020-10-13 |
| 2018-03-31 | $65.72K 10-Q · filed 2019-05-15 | |
| 2017-06-30 | $82.14K 10-K · filed 2019-08-23 | |
| 2016-06-30 | $142.59K 10-K · filed 2018-10-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |